Nicotine Patch + Placebo Patch + No Patch Control
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Smoking Cessation
Conditions
Smoking Cessation
Trial Timeline
Aug 1, 2005 → Oct 1, 2005
NCT ID
NCT00966901About Nicotine Patch + Placebo Patch + No Patch Control
Nicotine Patch + Placebo Patch + No Patch Control is a phase 1 stage product being developed by Johnson & Johnson for Smoking Cessation. The current trial status is completed. This product is registered under clinical trial identifier NCT00966901. Target conditions include Smoking Cessation.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT00966901 | Phase 1 | Completed |
Competing Products
20 competing products in Smoking Cessation